Regarding psoriasis, studies showed an improvement in psoriasis with GLP-1 receptor agonists by improving glycemic control, significant weight reduction, and possibly systemic anti-inflammatory effects [98,99,100]. The gene discussed is GLP1R; the disease is psoriasis.